Literature DB >> 24811567

The value of respective urodynamic parameters for evaluating the occurrence of complications linked to benign prostatic enlargement.

Xingliang Yang1, Kai Wang, Jiang Zhao, Wei Yu, Longkun Li.   

Abstract

PURPOSE: To assess the correlation between urodynamic parameters and urinary tract complications linked to benign prostatic enlargement (BPE), as well to assess the possible value of these parameters for predicting complications.
METHODS: We retrospectively analyzed the relationship between the complications and correlative urodynamic data of 486 BPH patients. Multivariate stepwise logistic regression was used to identify major independent predictors and establish regression models. Receiver operating characteristic (ROC) curves were constructed to evaluate the models' predictive values.
RESULTS: All of the individual parameters examined significantly correlated with most of the complications linked to BPE, except bladder calculus. According to ROC analysis, all of the areas under ROC curves (AUC), comparison of the individual parameters and the combined effects from the logistical regression models reached statistical significance (p < 0.05), and combining the parameters revealed a higher AUC compared to the individual parameters; however, all of the AUCs were below 0.9.
CONCLUSIONS: Urodynamic parameters are significantly correlated with most of the complications linked to BPE, and these parameters have predictive value for the occurrence of these complications with limited values.

Entities:  

Mesh:

Year:  2014        PMID: 24811567     DOI: 10.1007/s11255-014-0722-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  24 in total

1.  Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function.

Authors:  P Abrams
Journal:  BJU Int       Date:  1999-07       Impact factor: 5.588

Review 2.  Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 1: Nonurodynamic approach.

Authors:  Mohammed Belal; Paul Abrams
Journal:  J Urol       Date:  2006-07       Impact factor: 7.450

3.  The release of the clinical practice guideline: benign prostatic hyperplasia: diagnosis and treatment.

Authors:  N J Reilly
Journal:  Urol Nurs       Date:  1994-06

4.  Impact of primary hypertension on hematuria of the patients with benign prostatic hyperplasia.

Authors:  Li-jun Guo; Yuan Tang; Chao-ming Guo; Xiang-hua Zhang
Journal:  Chin Med J (Engl)       Date:  2010-05-05       Impact factor: 2.628

5.  International Consultation on Incontinence-Research Society (ICI-RS) report on non-invasive urodynamics: the need of standardization of ultrasound bladder and detrusor wall thickness measurements to quantify bladder wall hypertrophy.

Authors:  Matthias Oelke
Journal:  Neurourol Urodyn       Date:  2010-04       Impact factor: 2.696

6.  Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction.

Authors:  Victor W Nitti
Journal:  Rev Urol       Date:  2005

Review 7.  Emerging treatment options for benign prostatic obstruction.

Authors:  Brian A Parsons; Hashim Hashim
Journal:  Curr Urol Rep       Date:  2011-08       Impact factor: 3.092

Review 8.  Positioning invasive versus noninvasive urodynamics in the assessment of bladder outlet obstruction.

Authors:  Michiel Arnolds; Matthias Oelke
Journal:  Curr Opin Urol       Date:  2009-01       Impact factor: 2.309

9.  Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo.

Authors:  E David Crawford; Shandra S Wilson; John D McConnell; Kevin M Slawin; Michael C Lieber; Joseph A Smith; Alan G Meehan; Oliver M Bautista; William R Noble; John W Kusek; Leroy M Nyberg; Claus G Roehrborn
Journal:  J Urol       Date:  2006-04       Impact factor: 7.450

10.  Urodynamic findings before and after noninvasive management of bladder calculi.

Authors:  F Millán-Rodríguez; C Errando-Smet; F Rousaud-Barón; F Izquierdo-Latorre; A Rousaud-Barón; H Villavicencio-Mavrich
Journal:  BJU Int       Date:  2004-06       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.